Jefferies Downgrades Beacon Roofing Supply to Hold, Lowers Price Target to $56
Today, 3:36 PM
Jefferies analyst Philip Ng downgrades Beacon Roofing Supply (NASDAQ:BECN) from Buy to Hold and lowers the price target from $69 to $56.
Beacon Roofing Supply Q3 EPS $0.91 Misses $1.30 Estimate, Sales $1.87B Beat $1.81B Estimate
Today, 3:36 PM
Beacon Roofing Supply (NASDAQ:BECN) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate of $1.30 by 30 percent. This is a 9.9 percent decrease over earnings of $1.01 per share from
Earnings Scheduled For August 5, 2021
Today, 3:36 PM
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
Last Week’s Notable Insider Buys: Beacon Roofing Supply, Cricut, Crown Castle And More
Today, 3:36 PM
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
A couple of infrastructure-related companies attracted some notable insider buying last week.
Beneficial owners were in the spotlight again, as earnings season means buy windows are close for many insiders.
Unusual Options Activity Insight: Beacon Roofing Supply
Today, 3:36 PM
Shares of Beacon Roofing Supply (NASDAQ:BECN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $51.14.
Wells Fargo Initiates Coverage On Beacon Roofing Supply with Equal-Weight Rating, Announces Price Target of $58
Today, 3:36 PM
Wells Fargo analyst Deepa Raghavan initiates coverage on Beacon Roofing Supply (NASDAQ:BECN) with a Equal-Weight rating and announces Price Target of $58.
Uncategorized
Earnings Scheduled For May 6, 2021
Today, 3:36 PM
Companies Reporting Before The Bell
• ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
Uncategorized
Last Week’s Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More
Today, 3:36 PM
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs.
Once again, some insiders took advantage of recent public share offerings to add or bolster stakes.
Again, biotechnology companies are well represented on this list.